BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 17985639)

  • 1. Calculation of dose decrease in a finite phantom of a 192Ir point source.
    Melchert C; Kohr P; Schmidt R
    Med Phys; 2007 Oct; 34(10):3943-50. PubMed ID: 17985639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A CT-based analytical dose calculation method for HDR 192Ir brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Sep; 36(9):3982-94. PubMed ID: 19810471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The collapsed cone algorithm for (192)Ir dosimetry using phantom-size adaptive multiple-scatter point kernels.
    Tedgren ÅC; Plamondon M; Beaulieu L
    Phys Med Biol; 2015 Jul; 60(13):5313-23. PubMed ID: 26108232
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dosimetric comparison of 169Yb and 192Ir for HDR brachytherapy of the breast, accounting for the effect of finite patient dimensions and tissue inhomogeneities.
    Lymperopoulou G; Papagiannis P; Angelopoulos A; Karaiskos P; Georgiou E; Baltas D
    Med Phys; 2006 Dec; 33(12):4583-9. PubMed ID: 17278810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a scatter correction technique and its application to HDR 192Ir multicatheter breast brachytherapy.
    Poon E; Verhaegen F
    Med Phys; 2009 Aug; 36(8):3703-13. PubMed ID: 19746803
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of a phantom to validate high-dose-rate brachytherapy treatment planning systems with heterogeneous algorithms.
    Moura ES; Micka JA; Hammer CG; Culberson WS; DeWerd LA; Rostelato ME; Zeituni CA
    Med Phys; 2015 Apr; 42(4):1566-74. PubMed ID: 25832047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A BrachyPhantom for verification of dose calculation of HDR brachytherapy planning system.
    Austerlitz C; Campos CA
    Med Phys; 2013 Nov; 40(11):112103. PubMed ID: 24320456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of inhomogeneities and source position on dose distribution of nucletron high dose rate Ir-192 brachytherapy source by Monte Carlo simulation.
    Chandola RM; Tiwari S; Kowar MK; Choudhary V
    J Cancer Res Ther; 2010; 6(1):54-7. PubMed ID: 20479548
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A generic high-dose rate (192)Ir brachytherapy source for evaluation of model-based dose calculations beyond the TG-43 formalism.
    Ballester F; Carlsson Tedgren Å; Granero D; Haworth A; Mourtada F; Fonseca GP; Zourari K; Papagiannis P; Rivard MJ; Siebert FA; Sloboda RS; Smith RL; Thomson RM; Verhaegen F; Vijande J; Ma Y; Beaulieu L
    Med Phys; 2015 Jun; 42(6):3048-61. PubMed ID: 26127057
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Accuracy assessment of the superposition principle for evaluating dose distributions of elongated and curved 103Pd and 192Ir brachytherapy sources.
    Bannon EA; Yang Y; Rivard MJ
    Med Phys; 2011 Jun; 38(6):2957-63. PubMed ID: 21815369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A Monte Carlo calculation of dosimetric parameters of 90Sr/90Y and 192Ir SS sources for intravascular brachytherapy.
    Wang R; Li XA
    Med Phys; 2000 Nov; 27(11):2528-35. PubMed ID: 11128305
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of phantom material and dimensions on experimental 192Ir dosimetry.
    Carlsson Tedgren A; Carlsson GA
    Med Phys; 2009 Jun; 36(6):2228-35. PubMed ID: 19610312
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correction factors for source strength determination in HDR brachytherapy using the in-phantom method.
    Ubrich F; Wulff J; Engenhart-Cabillic R; Zink K
    Z Med Phys; 2014 May; 24(2):138-52. PubMed ID: 24021956
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brachytherapy source characterization for improved dose calculations using primary and scatter dose separation.
    Russell KR; Tedgren AK; Ahnesjö A
    Med Phys; 2005 Sep; 32(9):2739-52. PubMed ID: 16266087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part I: single sources and bounded homogeneous geometries.
    Zourari K; Pantelis E; Moutsatsos A; Petrokokkinos L; Karaiskos P; Sakelliou L; Georgiou E; Papagiannis P
    Med Phys; 2010 Feb; 37(2):649-61. PubMed ID: 20229874
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Phantom size in brachytherapy source dosimetric studies.
    Pérez-Calatayud J; Granero D; Ballester F
    Med Phys; 2004 Jul; 31(7):2075-81. PubMed ID: 15305460
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dosimetric accuracy of a deterministic radiation transport based 192Ir brachytherapy treatment planning system. Part II: Monte Carlo and experimental verification of a multiple source dwell position plan employing a shielded applicator.
    Petrokokkinos L; Zourari K; Pantelis E; Moutsatsos A; Karaiskos P; Sakelliou L; Seimenis I; Georgiou E; Papagiannis P
    Med Phys; 2011 Apr; 38(4):1981-92. PubMed ID: 21626931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dosimetric characterization of a novel intracavitary mold applicator for 192Ir high dose rate endorectal brachytherapy treatment.
    Poon E; Reniers B; Devic S; Vuong T; Verhaegen F
    Med Phys; 2006 Dec; 33(12):4515-26. PubMed ID: 17278803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dosimetric characterization of an 192Ir brachytherapy source with the Monte Carlo code PENELOPE.
    Casado FJ; García-Pareja S; Cenizo E; Mateo B; Bodineau C; Galán P
    Phys Med; 2010; 26(3):132-9. PubMed ID: 20034828
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The feasibility study and characterization of a two-dimensional diode array in "magic phantom" for high dose rate brachytherapy quality assurance.
    Espinoza A; Beeksma B; Petasecca M; Fuduli I; Porumb C; Cutajar D; Corde S; Jackson M; Lerch ML; Rosenfeld AB
    Med Phys; 2013 Nov; 40(11):111702. PubMed ID: 24320410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.